Cargando…
Anti-receptor activator of nuclear factor κB ligand antibody treatment increases osteoclastogenesis-promoting IL-8 in patients with rheumatoid arthritis
The receptor activator of nuclear factor κB ligand (RANKL) is an important factor for osteoclastogenesis and contributes to the pathology of rheumatoid arthritis (RA); thus, the anti-RANKL antibody (Ab) has been expected to protect joint destruction in RA patients. IL-8 also has osteoclastogenic act...
Autores principales: | Morita, Takayoshi, Shima, Yoshihito, Fujimoto, Kosuke, Tsuboi, Hideki, Saeki, Yukihiko, Narazaki, Masashi, Ogata, Atsushi, Kumanogoh, Atsushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484893/ https://www.ncbi.nlm.nih.gov/pubmed/30753461 http://dx.doi.org/10.1093/intimm/dxz009 |
Ejemplares similares
-
The Proportion of Regulatory T Cells in Patients with Rheumatoid Arthritis: A Meta-Analysis
por: Morita, Takayoshi, et al.
Publicado: (2016) -
Semaphorin 4D Contributes to Rheumatoid Arthritis by Inducing Inflammatory Cytokine Production: Pathogenic and Therapeutic Implications
por: Yoshida, Yuji, et al.
Publicado: (2015) -
572 Effect of Enzymatically Modified Isoquercitrin, a Flavonoid, on Symptoms of Japanese Cedar Pollinosis
por: Tanaka, Toshio, et al.
Publicado: (2012) -
Therapeutic efficacy of denosumab for rheumatoid arthritis: a systematic review and meta-analysis
por: Yagita, Mayu, et al.
Publicado: (2021) -
Increased levels of plasma nucleotides in patients with rheumatoid arthritis
por: Kishikawa, Toshihiro, et al.
Publicado: (2020)